Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,589 | 574 | 99.7% |
| Education | $15.25 | 1 | 0.2% |
| Consulting Fee | $12.53 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,508 | 152 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $796.23 | 60 | $0 (2024) |
| Janssen Biotech, Inc. | $675.05 | 56 | $0 (2024) |
| Gilead Sciences, Inc. | $632.46 | 33 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $442.28 | 27 | $0 (2024) |
| PFIZER INC. | $439.51 | 28 | $0 (2024) |
| Allergan Inc. | $380.77 | 27 | $0 (2019) |
| Braintree Laboratories, Inc. | $327.78 | 19 | $0 (2024) |
| Celgene Corporation | $307.63 | 19 | $0 (2023) |
| Ferring Pharmaceuticals Inc. | $299.00 | 23 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,606 | 71 | ABBVIE INC. ($409.39) |
| 2023 | $1,422 | 78 | ABBVIE INC. ($388.79) |
| 2022 | $1,233 | 67 | ABBVIE INC. ($473.48) |
| 2021 | $951.54 | 64 | AbbVie Inc. ($233.70) |
| 2020 | $547.82 | 37 | AbbVie Inc. ($173.60) |
| 2019 | $1,569 | 98 | AbbVie, Inc. ($313.58) |
| 2018 | $1,434 | 97 | AbbVie, Inc. ($360.01) |
| 2017 | $854.78 | 64 | Gilead Sciences Inc ($155.78) |
All Payment Transactions
576 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $30.62 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Immunology | ||||||
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZINPLAVA, ZERBAXA | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/10/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Rare Disease | ||||||
| 12/04/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $123.48 | General |
| Category: INFLAM | ||||||
| 12/04/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug), PLENVU | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Immunology | ||||||
| 11/22/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: IMMUNOLOGY | ||||||
| 11/16/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: VIROLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $107.75 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/30/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: GI COLON PREP | ||||||
| 10/29/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $14.04 | General |
| Category: GI | ||||||
| 10/24/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: LIVER DISEASE | ||||||
| 10/22/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/02/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Immunology | ||||||
| 09/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 924 | 1,012 | $405,376 | $94,818 |
| 2022 | 14 | 872 | 962 | $359,234 | $94,844 |
| 2021 | 13 | 740 | 833 | $296,853 | $77,194 |
| 2020 | 13 | 669 | 768 | $294,763 | $69,403 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 105 | 108 | $109,296 | $23,353 | 21.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 186 | 230 | $47,150 | $22,287 | 47.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 127 | 129 | $113,520 | $10,758 | 9.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 67 | 94 | $14,100 | $6,099 | 43.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 81 | 83 | $38,180 | $6,082 | 15.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 55 | 56 | $15,400 | $5,983 | 38.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $12,960 | $5,787 | 44.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 30 | $8,700 | $4,231 | 48.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 61 | $8,845 | $4,073 | 46.1% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 113 | 113 | $14,125 | $2,787 | 19.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 11 | 12 | $4,920 | $1,206 | 24.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,160 | $952.82 | 44.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 20 | 21 | $2,520 | $857.43 | 34.0% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $13,500 | $361.11 | 2.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 171 | 202 | $46,205 | $20,388 | 44.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 71 | 72 | $72,864 | $14,807 | 20.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 93 | 96 | $84,480 | $8,554 | 10.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 66 | 66 | $20,565 | $8,029 | 39.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 84 | 88 | $40,480 | $6,807 | 16.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 57 | 57 | $15,675 | $6,260 | 39.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 72 | 98 | $14,700 | $5,711 | 38.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 30 | 40 | $14,460 | $5,661 | 39.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 49 | 63 | $12,600 | $5,344 | 42.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 31 | 31 | $9,300 | $5,091 | 54.7% |
| 91200 | Measurement of liver stiffness | Office | 2022 | 88 | 88 | $11,000 | $2,183 | 19.8% |
About Dr. Kiley Walp, D.O
Dr. Kiley Walp, D.O is a Internal Medicine healthcare provider based in Doylestown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2009. The National Provider Identifier (NPI) number assigned to this provider is 1497981237.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kiley Walp, D.O has received a total of $9,617 in payments from pharmaceutical and medical device companies, with $1,606 received in 2024. These payments were reported across 576 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($9,589).
As a Medicare-enrolled provider, Walp has provided services to 3,205 Medicare beneficiaries, totaling 3,575 services with total Medicare billing of $336,260. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Doylestown, PA
- Active Since 06/08/2009
- Last Updated 08/03/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1497981237
Products in Payments
- XIFAXAN (Drug) $723.34
- RINVOQ (Biological) $588.04
- Humira (Biological) $548.18
- STELARA (Biological) $533.07
- ZEPOSIA (Drug) $466.75
- HUMIRA (Biological) $432.70
- SKYRIZI (Biological) $398.24
- XELJANZ (Drug) $347.20
- SUTAB (Drug) $231.37
- OMVOH (Drug) $226.92
- DUPIXENT (Biological) $202.29
- CLENPIQ (Drug) $201.54
- OCALIVA (Drug) $177.78
- ENTYVIO (Biological) $175.51
- VRAYLAR (Drug) $170.49
- Mulpleta (Drug) $167.51
- INTERSTIM (Device) $166.99
- REMICADE (Biological) $165.46
- Linzess (Drug) $158.65
- LINZESS (Drug) $151.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Doylestown
Dr. Mustafa Noor, M.d, M.D
Internal Medicine — Payments: $172,302
Michael Adenaike, Md, MD
Internal Medicine — Payments: $15,686
Dr. Luis Arzeno Tejada, M.d, M.D
Internal Medicine — Payments: $13,067
Dr. Richard Kondan, Do, DO
Internal Medicine — Payments: $10,318
Austin Liu, Md, MD
Internal Medicine — Payments: $8,344
Oleg Vinnikov, Md, MD
Internal Medicine — Payments: $6,126